IFNGR1 and systemic sclerosis: In the case of polymorphisms identified at chr1_67833501 (IL-12RB2) and chr6_137519588 (IFNGR1), the benign significance reported in the literature was not confirmed by our results, which instead suggests these polymorphisms as predisposing in SLE and SSc, respectively.